Anti-human tie-2 antibody

METHODS FOR INHIBITING FIBROSIS IN A SUBJECT IN NEED THEREOF

Antibodies against CD73

GALACTOENGINEERED IMMUNOGLOBULIN 1 ANTIBODIES

Anti-GD2 antibodies

Antibodies to CD40 with enhanced agonist activity

CD94/NKG2A AND/OR CD94/NKG2B ANTIBODY, VACCINE COMBINATIONS

Anti-CD74 antibodies, compositions comprising anti-CD74 antibodies and methods of using anti-CD74 antibodies

Anti-PD-L1 antibodies and uses thereof

Anti-PD-L1 antibodies and uses thereof

INHIBITION OF BONE RESORPTION WITH RANKL BINDING PEPTIDES

Methods of Suppressing Rheumatoid Arthritis Using An Anti-IL-6 Antibody

Eribulin-based antibody-drug conjugates and methods of use

Immuno-based retargeted endopeptidase activity assays

Therapeutic antibodies against ROR-1 protein and methods for use of same

Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases

PROTEASE-ACTIVATABLE BISPECIFIC PROTEINS

Bispecific binding molecules binding to VEGF and Ang2

Express humanization of antibodies

Anti-AGE antibodies for treating inflammation and auto-immune disorders

Human-derived anti-dipeptide repeats (DPRs) antibody

COMPOSITIONS FOR INHIBITION OF QUIESCIN SULFHYDRYL OXIDASE (QSOX1) AND USES OF SAME

BISPECIFIC ANTIBODIES WITH TETRAVALENCY FOR A COSTIMULATORY TNF RECEPTOR

Modulating Agonistic TNFR Antibodies

DAC HYP compositions

COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF

Safety for Treating Cancers with a Glycosylated Chimeric Antibody to EGFR

Antibody molecules to PD-1 and uses thereof

ANTI-PD1 ANTIBODIES AND METHODS OF USE

Soluble engineered monomeric Fc

Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof

Human PAC1 antibodies

Immunological treatment of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

Humanized anti-hepcidin antibodies and uses thereof

Anti-IL-1beta antibodies

Anti-ANG2 antibodies and methods of use

Anti-PDGF-B antibodies and methods of use

Norovirus antibodies

T-cell redirecting bispecific antibodies for treatment of disease

Interleukin-15 compositions and uses thereof

LOX and LOXL2 inhibitors and uses thereof

Anti-ErbB antibodies and methods of use thereof

Anti-CD40 antibodies and methods of treating cancer having CD40+ tumor cells

Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies

Human monoclonal antibodies against CD25

Antibodies, compositions, and uses

Anti-TIM-3 antibodies

COMPOSITIONS AND METHODS FOR IDENTIFYING AND TREATING CACHEXIA OR PRE-CACHEXIA

ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF

Bispecific antibodies and methods of use in ophthalmology

Midkine antibody

BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

Antagonist antibodies directed against calcitonin gene-related peptide

Antagonist antibodies directed against calcitonin gene-related peptide

Anti-polyubiquitin antibodies and methods of use

MODIFIED VARIABLE DOMAIN MOLECULES AND METHODS FOR PRODUCING THEM

ANTI-B7-H4 ANTIBODIES AND IMMUNOCONJUGATES

Heterodimeric antibody Fc-containing proteins and methods for production thereof

Antibodies specific for MMP9

Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation

HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain II of HER2

Anti-Clusterin Antibodies and Antigen Binding Fragments and their Use to Reduce Tumor Volume

POLYNUCLEOTIDES ENCODING ANTI-NOTCH1 NRR ANTIBODY POLYPEPTIDES

ANTI-CD40 ANTIBODIES AND USES THEREOF

Anti-CD40 antibodies

ANTI-VEGFR ANTIBODY AND USES THEREOF

Method of identifying anti-VISTA antibodies

Antibodies directed against ICOS and uses thereof

Antibody Therapeutics That Bind CTLA4

ANTIBODIES BINDING TO HUMAN AND CYNOMOLGUS CD3 EPSILON

ROR1-Binding Molecules, and Methods of Use Thereof

Prophylaxis of colorectal and gastrointestinal cancer

IL-17 ANTAGONIST ANTIBODIES

Anti-dengue virus NS1 protein monoclonal antibodies

Fusions of antibodies to CD38 and attenuated interferon alpha

Anti-complement C1s antibodies

Anti-complement C1s antibodies

Compositions to regulate renalase in the treatment of diseases and disorders

Thrombin-binding antibody molecules and uses thereof

Anti-coagulation factor XI antibodies

Tumor antigen specific antibodies and TLR3 stimulation to enhance the performance of checkpoint interference therapy of cancer

Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said

Antibody therapeutics that bind CD137

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

Human anti-FGFR4 antibody

Anti-CTLA-4 antibodies

Antibodies directed to Fc gamma receptor IIB and Fc epsilon receptor

Anti-human Igβ antibody

Antibodies With Modified Affinity To FcRn That Promote Antigen Clearance

CD7 nanobodies, encoding sequence and use thereof

Anti-Orai1 antibody

Methods of diagnosing and treating hyperproliferative disorders

Anti-TNFα antibodies with pH-dependent antigen binding for improved target clearence

Anti-OSPA antibodies and methods of use

ADENOCARCINOMA ANTIGENIC DETERMINANTS AND METHODS

Methods for treating multiple myeloma

Mice that make Vbinding proteins

Antibodies with high affinity for alpha-Klotho

ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVATIVES THEREOF

Method for positioning, in cytoplasm, antibody having complete immunoglobulin form by penetrating antibody through cell membrane, and use for same

HER2/neu-specific antibodies and methods of using same

Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)

Oncostatin M receptor antigen binding proteins

Development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies

Anti-epidermal growth factor receptor (EGFR) antibodies

Antibody gene expression-secretion system

Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen and Uses Thereof

Antigen binding proteins that bind PD-L1

ANTI-GLUCAGON ANTIBODIES AND USES THEREOF

Methods of Using IL-1beta Compounds

Methods of treatment using anti-GM-CSF antibodies

Methods for treating thrombosis using chimeric and humanized anti-histone antibodies

HUMANIZED ANTIBODIES SPECIFIC FOR HSP65-DERIVED PEPTIDE-6, METHODS AND USES THEREOF

Compositions and methods related to antibodies to Staphylococcal protein A

Neutralizing anti-influenza B antibodies and uses thereof

CROSS-REACTIVE ANTIBODIES AGAINST DENGUE VIRUS AND USES THEREOF

Immunoglobulin constant region Fc receptor binding agents

ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION

Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy

COMPOSITIONS AND METHODS FOR RAPID PRODUCTION OF VERSATILE NANOBODY REPERTOIRES

Velocity factor

Antibodies that recognize red blood cell antigens

Bispecific HER2 and CD3 binding molecules

Anti-PDGFR-beta antibodies and uses thereof

Antibodies specific for epidermal growth factor receptor variant III and their uses

Chimeric antigen receptors targeting epidermal growth factor receptor variant III

BISPECIFIC BINDING AGENTS TARGETING THE IGF-1R AND ERBB3 PATHWAYS AND USES THEREOF

Anti-sortilin antibodies and methods of use thereof

HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR

Anti-PD-1 antibody and use thereof

Antibody binding to FcRn for treating autoimmune diseases

Multispecific antigen binding proteins

Antibody binding to FcRn for treating autoimmune diseases

Methods for improving cardiac function by administering an antibody that activates APLNR

ANTI-ROR1, ANTIBODIES, ROR1 X CD3 BISPECIFIC ANTIBODIES, AND METHODS OF USING THE SAME

Antibodies that bind human cannabinoid 1 (CB1) receptor

Human antibodies to Fel d1 and methods of use thereof

SERUM ALBUMIN BINDING PROTEINS

Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors

Influenza virus vaccines and uses thereof

ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

Antibodies that bind thermophilic DNA polymerases

Modified antigen binding polypeptide constructs and uses thereof

Anti-CD3 antibodies and methods of use

Antibody Fc Mutants with Ablated Effector Functions

Anti-FGFR3 antibodies and methods using same

Anti-PD-L1 antibodies

VH-VL-INTERDOMAIN ANGLE BASED ANTIBODY HUMANIZATION

CD33 antibodies and use of same to treat cancer

Molecules with specificity for CD79 and CD22

Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind to multiple cancer antigens

Anti-N3pGlu amyloid beta peptide antibodies and uses thereof

Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein

NEUTRALIZING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USES THEREOF

High affinity human antibodies to human cytomegalovirus (CMV) gB protein

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension

Semi-synthetic nurse shark VNAR libraries for making and using selective binding compounds

COMPOSITIONS CAPABLE OF SPECIFICALLY BINDING PARTICULAR HUMAN ANTIGEN PRESENTING MOLECULE/ ANTIGEN COMPLEXES AND USES THEREOF

Multi-chain polypeptide-containing tri-specific binding molecules

ANTI-TIGIT ANTIBODIES

Antibody molecules to TIM-3 and uses thereof

NKp46 binding proteins

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

Nucleic acid encoding anti-IL-17A antibodies

Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies

NOTCH BINDING AGENTS AND ANTAGONISTS AND METHODS OF USE THEREOF

Antibody-albumin nanoparticle complexes comprising albumin, bevacizumab, and paclitaxel, and methods of making and using the same

Nanoparticle complexes of paclitaxel, alemtuzumab, and albumin

Nanoparticle complexes of paclitaxel, trastuzumab, and albumin

Carrier immunoglobulins

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Valyl-tRNA synthetases

Anti-EGFR conformational single domain antibodies and uses thereof

Bispecific T cell activating antigen binding molecules

Methods of treating with anti-PSGL-1 antibodies

Antibody molecules to TIM-3 and uses thereof

Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)

Ligands that potentiate the bioactivity of gonadotropins

Ligands that potentiate the bioactivity of gonadotropins

HUMAN MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN 8 (IL-8)

Compositions and methods for growth factor modulation

Antibodies and conjugates thereof

Alpha-synuclein antibodies and uses thereof

Human immunodeficiency virus neutralizing antibodies

Methods of treating cancer by administering IGF-IR binding molecules

Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof

Suppression of myeloid derived suppressor cells and immune checkpoint blockade

Methods for inhibiting fibrosis in a subject in need thereof

Monoclonal antibodies that specifically block biological activity of a tumor antigen

METHOD OF DETECTING HUMAN MATRIX METALLOPROTEINASE 9 USING ANTIBODIES

ANTIBODIES TO OPGL

Cysteine engineered antibodies for site-specific conjugation

HIGHLY-FUNCTIONAL IgG2 BISPECIFIC ANTIBODY

ANTIBODY SCAFFOLD FOR HOMOGENOUS CONJUGATION

Modified immunoglobulin molecules that specifically bind human VEGF and DLL4

Immune-stimulating monoclonal antibodies against human interleukin-2

HYPOGLYCEMIC AGENT CONTAINING ANTI-ANG2 ANTIBODY

IMMUNOPOTENTIATOR CONTAINING ANTI-ANG2 ANTIBODY

Rodent combinatorial antibody libraries

Lyophilized compositions comprising albumin-rankl or albumin-GD2 paclitaxel nanoparticle complexes

Methods of using albumin-antibody nanoparticle complex compositions for treating cancer

Methods of using albumin-CD20 paclitaxel nanoparticle complex compositions for treating cancer

Lyophilized compositions comprising albumin-antibody paclitaxel nanoparticle complexes

Albumin-PD-1 paclitaxel nanoparticle complex compositions and methods of making and using the same

Lyophilized compositions comprosing albumin-EGFR paclitaxel nanoparticle complexes

Albumin-CTLA-4 paclitaxel nanopartilce complex compositions and methods of making and using the same

Methods of making lyophilized compositions comprising albumin-VEGF paclitaxel nanoparticle complexes

Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms

Internalizing moieties

Anti-TIE2 antibodies and uses thereof

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Anti-HER3 antibodies and uses thereof

Single-Arm Monovalent Antibody Constructs and Uses Thereof

Anti-HER2 antibodies and immunoconjugates

pH-dependent antibodies targeting the transferrin receptor and methods of use thereof to deliver a therapeutic agent

Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein

Polypeptides, antibody variable domains and antagonists

Polynucleotides encoding rodent antibodies with human idiotypes and animals comprising same

Anti-FGFR1c antibody-FGF21 fusion proteins

ICOS binding proteins

Construction and application of bispecific antibody HER2xCD3

Biparatopic polypeptides antagonizing Wnt signaling in tumor cells

Monoclonal antibodies to progastrin and their uses

Stabilized angiopoietin-2 antibodies and uses thereof

Methods of treating a tauopathy

METHOD FOR TREATING BREAST CANCER

IMMUNOGENETIC RESTRICTION ON ELICITATION OF ANTIBODIES

Biotin Derivatives

Site-specific antibody-drug glycoconjugates and methods

Anti-folate receptor alpha antibodies and uses thereof

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

Methods for treating conditions associated with MASP-2 dependent complement activation

ANTI-HER2 ANTIBODY VARIANTS

NOVEL IMMUNOGLOBULIN VARIANTS

Antibodies for epidermal growth factor receptor 3 (HER3)

Antibody variants composition

Humanized antibodies against CD269 (BCMA)

Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2)

Immunological reagents

USE OF CD-64-BLOCKING AGENTS AS ENHANCER OF AN ANTI-TNF-a ANTIBODY THERAPY

Compositions comprising anti-CEACAM1 and anti-PD antibodies for cancer therapy

Method of treating retinopathy with an anti-LRP5 antibody

P2X4 antibodies and uses thereof

ANTIBODIES AGAINST THE RGM A PROTEIN AND USES THEREOF

Human derived anti-Huntingtin (HTT) antibodies and uses thereof

HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF

Fibronectin based scaffold proteins having improved stability

Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins

BCMA Antigen binding proteins

Antibody-SN-38 immunoconjugates with a CL2A linker

Anti-TIGIT antigen-binding proteins and methods of use thereof

Methods for treating cancer by administering humanized pan-HER antibody compositions

Host cells for use in an inducible coexpression system

Methods of treating a kit-associated cancer by administering anti-kit antibodies

Method for inhibiting intracellular activated RAS using intact immunoglobulin-type antibody having cytosol-penetrating ability and use thereof

ANTI-C4.4A ANTIBODIES AND USES THEREOF

IMMUNOGLOBULIN VARIANTS AND USES THEREOF

COMPOSITIONS OF ANTIBODY CONSTRUCT - AGONIST CONJUGATES AND METHODS OF USE THEREOF

HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1)

ANTIBODIES DIRECTED AGAINST DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 1 (DDR1)

IP-10 antibodies and their uses

Caninized anti-NGF antibodies and methods thereof

Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses

MONOCLONAL ANTIBODIES DIRECTED AGAINST ENVELOPE GLYCOPROTEINS FROM MULTIPLE FILOVIRUS SPECIES

Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof

Antibodies binding AXL

COMPOSITIONS AND METHODS FOR PRODUCING GLYCOPROTEINS

Antigen binding formats for use in therapeutic treatments or diagnostic assays

IL3Rα antibody conjugates and uses thereof

Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodies

Antigen binding proteins to oncostatin M (OSM)

M-CSF specific monoclonal antibody and uses thereof

Antibodies recognizing α-synuclein

Anti-complement factor C1q Fab fragments and uses thereof

TDP-43 specific binding molecules

Anti-huLRRC15 antibody drug conjugates and methods for their use

Anti-huLRRC15 antibody drug conjugates and methods for their use

Site specific HER2 antibody drug conjugates

Formulation of human antibodies for treating TNF-alpha associated disorders

Lysine monomethylated derivative and corresponding antibody and use thereof

TETRAVALENT MULTISPECIFIC ANTIBODIES

BIOLOGICAL PRODUCTS

Anti-HtrA1 antibodies and methods of use thereof

Anti-factor D antibodies and conjugates

Anti-MCAM antibodies and associated methods of use

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Fab FRAGMENT SPECIFICALLY BINDING TO EGFR

Human monoclonal antibodies specific for CD22

Methods for achieving therapeutically effective doses of anti-CD47 agents

Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

Method of treating idiopathic pulmonary fibrosis by administering human oncostatin M antibodies

Antibody to GDF8 and uses thereof

LIGAND

specific antibodies

Anti-factor D antibody variant conjugates and uses thereof

Chemically-locked bispecific antibodies